SRR934900
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR934748 | — | — | 0.932 |
| 2 | C635C019-A66D-42B7-911C-4D0742CAF95A | — | — | 0.931 |
| 3 | SRR934744 | — | — | 0.928 |
| 4 | 98D004A9-E3F0-448E-BFE2-359F25DF356C | — | — | 0.907 |
| 5 | SRR934990 | — | — | 0.905 |
| 6 | SRR934893 | — | — | 0.903 |
| 7 | DD5AA3F8-E3EE-4EDD-8152-B1CC07B70A08 | — | — | 0.903 |
| 8 | D902E43A-F384-432A-B690-D20BFCC78443 | — | — | 0.901 |
| 9 | SRR934902 | — | — | 0.897 |
| 10 | SRR934873 | — | — | 0.893 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 24 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.685 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.667 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.609 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.603 | Idelalisib | — uncovered |
| MITOTIC_SPINDLE | 0.474 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.436 | Idelalisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.433 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.338 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.321 | Inavolisib | — uncovered |
| MTORC1_SIGNALING | 0.283 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.248 | Remibrutinib | — uncovered |
| PROTEIN_SECRETION | 0.242 | Remibrutinib | — uncovered |
| NOTCH_SIGNALING | 0.189 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.149 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.105 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.061 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.057 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.051 | Inavolisib | — uncovered |
| GLYCOLYSIS | 0.033 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.033 | Inavolisib | — uncovered |